Specialty code 390200000X · West Hollywood, CA
NPI
1699120782
Since 2016
Specialty
Specialty code 390200000X
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8700 Beverly Blvd # 5512
West Hollywood, CA, 90048
Phone (310) 423-5161
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.3M
1,342 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Elad Neeman prescribed most often to Medicare patients was Prednisone, with 92 prescriptions and refills. In total Elad Neeman wrote 1,342 Medicare prescriptions that cost $4.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 92 | 219 | 47 | $935 |
| Dexamethasone Generic | 85 | 112 | 39 | $1,993 |
| Abiraterone Acetate Generic | 82 | 154 | 26 | $20K |
| Lenalidomide Generic | 81 | 81 | 13 | $910K |
| Acyclovir Generic | 79 | 169 | 30 | $2,090 |
| Prochlorperazine Maleate Generic | 51 | 51 | 36 | $660 |
| Ondansetron Hcl Generic | 41 | 41 | 28 | $343 |
| Brukinsa Zanubrutinib | 39 | 39 | Under 11 | $411K |
| Nivestym Filgrastim-Aafi | 31 | 31 | 12 | $23K |
| Hydroxyurea Generic | 27 | 55 | Under 11 | $1,124 |
| Granix Tbo-Filgrastim | 26 | 26 | Under 11 | $11K |
| Tagrisso Osimertinib Mesylate | 25 | 25 | Under 11 | $422K |
| Atorvastatin Calcium Generic | 24 | 80 | 11 | $285 |
| Furosemide Generic | 23 | 60 | 15 | $250 |
| Potassium Chloride Generic | 22 | 45 | 13 | $518 |
Brand drugs: 368 claims; generic drugs: 974 claims; opioid claims: 26.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Elad Neeman were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.